As of Oct 25
| +0.32 / +0.65%|
The 22 analysts offering 12-month price forecasts for Bristol-Myers Squibb have a median target of 64.00, with a high estimate of 100.00 and a low estimate of 50.00. The median estimate represents a +29.16% increase from the last price of 49.55.
The current consensus among 26 polled investment analysts is to Hold stock in Bristol-Myers Squibb. This rating has held steady since October, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.